Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?

R Pofi, G Caratti, DW Ray, JW Tomlinson - Endocrine Reviews, 2023 - academic.oup.com
It is estimated that 2% to 3% of the population are currently prescribed systemic or topical
glucocorticoid treatment. The potent anti-inflammatory action of glucocorticoids to deliver …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

JS Smolen, R Landewé, FC Breedveld… - Annals of the …, 2010 - ard.bmj.com
Treatment of rheumatoid arthritis (RA) may differ among rheumatologists and currently, clear
and consensual international recommendations on RA treatment are not available. In this …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

JS Smolen, R Landewé, FC Breedveld… - Annals of the …, 2014 - ard.bmj.com
In this article, the 2010 European League against Rheumatism (EULAR) recommendations
for the management of rheumatoid arthritis (RA) with synthetic and biological disease …

Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy

RS Hardy, H Zhou, MJ Seibel, MS Cooper - Endocrine reviews, 2018 - academic.oup.com
Osteoporosis associated with long-term glucocorticoid therapy remains a common and
serious bone disease. Additionally, in recent years it has become clear that more subtle …

Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial …

SB Cohen, P Emery, MW Greenwald… - Arthritis & …, 2006 - Wiley Online Library
Objective To determine the efficacy and safety of treatment with rituximab plus methotrexate
(MTX) in patients with active rheumatoid arthritis (RA) who had an inadequate response to …

Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids

D Czock, F Keller, FM Rasche, U Häussler - Clinical pharmacokinetics, 2005 - Springer
Glucocorticoids have pleiotropic effects that are used to treat diverse diseases such as
asthma, rheumatoid arthritis, systemic lupus erythematosus and acute kidney transplant …

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis

M Boers, AC Verhoeven, HM Markusse… - The Lancet, 1997 - thelancet.com
Background The value of intensive combination therapy in early rheumatoid arthritis is
unproven. In a multicentre, double-blind, randomised trial (COBRA), we compared the …

Guidelines for the management of rheumatoid arthritis: 2002 update

American College of Rheumatology … - Arthritis & …, 2002 - Wiley Online Library
Rheumatoid arthritis (RA) is an autoimmune disorder of unknown etiology characterized by
symmetric, erosive synovitis and, in some cases, extraarticular involvement (1). Most …

[图书][B] Handbook of nutraceuticals and functional foods

REC Wildman, R Wildman, TC Wallace - 2016 - taylorfrancis.com
Scientific advances in this field have not only given us a better understanding of what is an
optimal diet, but has allowed food and nutraceutical companies to market products with …

Dose-related patterns of glucocorticoid-induced side effects

D Huscher, K Thiele, E Gromnica-Ihle, G Hein… - Annals of the …, 2009 - ard.bmj.com
Objective: To identify patterns of self-reported health problems relating to dose and duration
of glucocorticoid intake in unselected patients with rheumatoid arthritis from routine practice …